Bronchodilation + 2-FMA
2-FMA is known to produce bronchodilation, a physical effect. Bronchodilation is the widening of the bronchial airways in the lungs, reducing resistance to airflow and producing a subjective sensation of easier, deeper, and more comfortable breathing.
About Bronchodilation
Bronchodilation refers to the relaxation and widening of the bronchial tubes — the airways that carry air into and out of the lungs. When the smooth muscle surrounding these airways relaxes, the internal diameter increases, reducing resistance to airflow and allowing more air to flow freely with each breath. Subjectively, this manifests as breathing feeling noticeably easier, deeper, and more satisfying than normal, as if a subtle restriction that one had not even been aware of has been lifted.
The pharmacological mechanisms of bronchodilation are well established. Beta-2 adrenergic agonists — the mechanism underlying many prescription asthma inhalers (albuterol, salbutamol) — directly relax bronchial smooth muscle. Stimulants like amphetamine and methamphetamine produce bronchodilation as a secondary effect of their sympathomimetic activity, activating the same beta-2 receptors alongside their primary catecholaminergic effects.Anticholinergics (including some deliriants) relax bronchial muscle by blocking the muscarinic receptors that normally promote bronchoconstriction.Methylxanthines like theophylline (chemically related to caffeine) have been used as bronchodilators for over a century. Cannabis and othercannabinoid receptor agonists also demonstrate acute bronchodilatory effects, somewhat paradoxically given that smoked cannabis also irritates the airways.
For individuals with asthma or other obstructive airway conditions, the bronchodilatory effects of certain substances can be subjectively dramatic — suddenly breathing becomes effortless in a way they rarely experience. However, self-medicating respiratory conditions with recreational substances is inadvisable, as the bronchodilation is typically accompanied by numerous other pharmacological effects that may be harmful, and the dosing is imprecise compared to purpose-designed medical bronchodilators.
The effect is most commonly noticed with stimulants, caffeine at moderate-to-high doses, and cannabis (during the acute phase, before any inflammatory irritation from smoke sets in). For most users without pre-existing respiratory conditions, the bronchodilation is a subtle background effect that contributes to a general sense of physical well-being but is not a dominant feature of the experience.